Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

Two screens, one bold future. Dual-display laptops are finally practical in 2025—great for creators, coders, and pros who ...

World Team Trials get underway tomorrow. Friday and Saturday, some of our nation's best will head to Louisville, Kentucky in search of a spot in Final X. There is at least one wrestler per weight in ...

Vulnerable groups in Pangasinan have expressed gratitude to the national government on Thursday as the P20-per-kilo rice ...

With the new 2025 AllMtn CF 11 TRN/IQ, Haibike join the gearbox revolution, equipping their bike with Pinion’s MGU ...

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...

SHEEP industry confidence is low under the current seasonal conditions, but feed allowing, there are still opportunities in ...

STILLWATER – Former Oklahoma State wrestlers Dustin Plott and Dean Hamiti Jr. , as well as current Cowboy Carter Young , ...

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of ...

According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.

Men with gout and obesity receiving febuxostat-based ULT were less likely to achieve SU targets and more frequently experienced disease flares.